Lisa Shea: Working Toward Better Outcomes in High-Risk Pregnancy
Lisa Shea, Director, Global Patient Advocacy and Engagement – Rare Autoantibody at Johnson & Johnson, shared a post on LinkedIn:
“This week, I’m proud to recognize High Risk Pregnancy Awareness Week and the maternal-fetal medicine and OBGYN communities working to support families facing complex pregnancies.
At Johnson & Johnson Innovative Medicine, we’re proud to be advancing the field of maternal-fetal immunology, with a focus on driving awareness of hemolytic disease of the fetus and newborn (HDFN) and fetal and neonatal alloimmune thrombocytopenia (FNAIT).
Together with the broader patient, prenatal diagnostic, and healthcare communities, we are working toward solutions that meet the real needs of individuals and their families navigating high-risk pregnancies, including those impacted by alloantibody diseases like HDFN and FNAIT.”
The Society for Maternal-Fetal Medicine shared a post on LinkedIn:
“June 1- 8 is High Risk Pregnancy Awareness Week!
The week is more than an awareness initiative, it’s a movement to transform the conversation around high-risk pregnancy care.
What is a high-risk pregnancy?
A pregnancy can be classified as high-risk for many reasons, a chronic condition like diabetes or high blood pressure, a complication that develops during pregnancy like preeclampsia or preterm labor, or concerns about fetal health like a genetic disorder or birth defect.”
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 07:36Johannes Kaesmacher: Cerebral No-Reflow After Thrombectomy Toward a Standardized Definition
-
Oct 19, 2026, 07:33Beth Psaila: Highlights from IACH Annual Meeting and MPN Horizons
-
Oct 19, 2026, 07:29Wolfgang Miesbach: Can Losartan Activate Brown Fat? – Nature Study Explores New Therapeutic Link
-
Oct 19, 2026, 07:22Ruben Mesa: Honored to Speak at the Tandem MPN Meetings of IACH
-
Oct 19, 2026, 07:19Saneha Anjum Shaikh: Parul University Partners with Raktasevak Bike Ride 2026 for Blood Donation Drive
-
Oct 19, 2026, 07:09Alejandro González Veliz: No ST Elevation Does Not Guarantee an Open Coronary Artery
-
Oct 19, 2026, 06:02Thomas Dayspring: Vascular Resilience – What Is It and How Can We Measure It?
-
Oct 19, 2026, 05:53Kevon Dindial: Collaboration for Better Childhood Cancer Outcomes
-
Oct 19, 2026, 05:44Mavis Agnes Kisakye: Raising Awareness about Haemophilia and Other Blood Disorders at Luweero General Hospital